Showing 3431-3440 of 4902 results for "".
It's Time to Get Serious About Scalp Psoriasis Treatment
https://practicaldermatology.com/topics/practice-management/its-time-to-get-serious-about-scalp-psoriasis-treatment/20545/Largely due to adherence issues, topical treatments don't work for many scalp psoriasis patients.Key Characteristics That Drive Practice Valuation
https://practicaldermatology.com/topics/practice-management/key-characteristics-that-drive-practice-valuation/20417/It makes good business sense to optimize value, whether looking to sell soon, in the future, or never.Bio-Logistics: Steps for Improving Access to Biologic Therapy
https://practicaldermatology.com/topics/practice-management/bio-logistics-steps-for-improving-access-to-biologic-therapy/21192/Dealing with insurance companies can be a burden for many practices, but here are some steps to help expedite the process.First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Melanoma Mortality: Women Maintain the Advantage
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-mortality-women-maintain-the-advantage/20387/Global data show that men have higher rates of mortality and more rapid melanoma progression. We still don't know why.What Every Dermatologist Should Know About AI
https://practicaldermatology.com/topics/practice-management/what-every-dermatologist-should-know-about-ai/23569/As augmented intelligence evolves, here are seven things every dermatologist should know about its potential and its limitations.Extended Half-Life and Long-Acting Biologics for the Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/extended-half-life-and-long-acting-biologics-for-the-treatment-of-psoriasis/60876/Explore the biologic rationale, emerging clinical candidates, and key unanswered questions surrounding extended half-life therapies for psoriatic disease.Basal Cell Carcinoma in Skin of Color: A Case Series
https://practicaldermatology.com/topics/skin-cancer-photoprotection/basal-cell-carcinoma-in-skin-of-color-a-case-series/23814/BCC is not common in patients with skin of color; it tends to have a delayed diagnosis and can have a more serious disease course.The ACTS Program: Adding Testing to Your Defense Against COVID-19
https://practicaldermatology.com/issues/supplements/the-acts-program-adding-testing-to-your-defense-against-covid-19/23419/Adopting a simple testing and safety platform for personal protective equipment and sterilization protocols adds a layer of protection for patients and office staff.What’s Great About Your Practice? And Why Does That Really Matter?
https://practicaldermatology.com/topics/practice-management/whats-great-about-your-practice-and-why-does-that-really-matter/24008/The importance of a clear mission, vision, and core values.